9/11 first responders still facing delays despite funding restored to health program
NEW YORK - Staffing reductions by the Department of Government Efficiency have led to major delays in healthcare services for thousands 9/11 first responded and survivors.
While funding cuts were reversed in February following public backlash, staffing shortages and long wait times remain an ongoing problem.
What we know
In February, DOGE implemented a 20% staff reduction within the World Trade Center Health Program, a federal initiative under the CDC that provides medical care to 9/11 first responders and survivors. Although some funding was reinstated following public backlash, many positions remain unfilled, causing prolonged delays in patient services.
Michael Barasch, an attorney representing the 9/11 community, highlighted the issue: "The rules are that you can't get treated until you're certified with a 9/11 illness. But if you can't get an appointment to get your illness certified, that's essentially taking away your treatment."
The backstory
Established to offer free annual health exams and treatment for 9/11-related conditions, the World Trade Center Health Program currently serves approximately 130,000 individuals nationwide. The program's efficiency has been compromised due to staffing cuts, affecting its ability to certify new patients and provide timely care.
Retired FDNY Lt. Michael O'Connell shared his experience: "In 2007, I wound up developing a very rare autoimmune disease called sarcoidosis. The World Trade Center Health Program literally saves lives. It saved me."
What's next
In addition to restoring the funding that was previously cut, advocates for the 9/11 community are now pushing lawmakers in Washington to increase federal support by another $3 billion.
They argue that more than two decades after the Twin Towers collapsed, people are still getting sick—and still dying—from 9/11-related conditions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
2 hours ago
- Medscape
CVD Mortality Higher in Women With Inflammatory Diseases
Although cardiovascular disease (CVD)-related mortality decreased significantly from 1999 to 2020 in both men and women with immune-mediated inflammatory diseases (IMIDs), women consistently had higher rates of CVD-related mortality than men over the 22-year period. METHODOLOGY: Researchers analyzed CDC Multiple Cause of Death files from 1999 to 2020 to assess the sex differences in CVD-related mortality in patients with IMIDs. They identified CVD-related deaths with underlying IMIDs in the United States using diagnostic codes. IMIDs such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis were analyzed. The analysis included 281,355 IMID-related deaths and 127,149 CVD-related deaths over a period of 22 years. Annual crude and adjusted death rates were estimated. TAKEAWAY: Age-adjusted CVD-related mortality for women with IMIDs declined from 3.3 per 100,000 in 1999 to 1.4 per 100,000 in 2020, whereas the rate in men with IMIDs declined from 2.3 to 1.1 per 100,000 ( P < .01). < .01). However, women had higher mortality than men throughout the study duration (mortality rate ratio, 1.5; P < .01). < .01). Cerebrovascular disease and ischemic heart disease were major causes of death, with women more affected than men; women experienced mortality from arrhythmia and cardiac arrest at more than twice the rate of men. Among patients with IMIDs, women with rheumatoid arthritis had disproportionately higher crude CVD-related mortality than men with rheumatoid arthritis. IN PRACTICE: 'Addressing these risks requires increasing awareness of atypical cardiovascular symptoms in females with IMIDs, enhancing early detection through advanced imaging, and ensuring equitable access to therapies like biologics,' the study authors wrote. SOURCE: This study was led by Issam Motairek, MD, Cleveland Clinic, Cleveland. It was published online on May 5, 2025, in Circulation: Cardiovascular Quality and Outcomes . LIMITATIONS: The potential inaccuracies in the codes for identifying the cause of death may have misclassified IMIDs or CVD-related causes. The aggregate data structure prevented the analyses of individual-level factors such as severity of disease or treatments. Less common IMIDs were excluded, which may have underestimated their contribution to CVD. DISCLOSURES: This study received no specific funding. The authors reported having no conflicts of interest.
Yahoo
4 hours ago
- Yahoo
US Health Secretary Kennedy guts vaccine advisory committee
By Ahmed Aboulenein, Michael Erman and Julie Steenhuysen WASHINGTON (Reuters) -Health Secretary Robert F. Kennedy Jr. has fired all 17 members of a U.S. Centers for Disease Control and Prevention panel of vaccine experts and is in the process of replacing them, his department said on Monday, drawing protest from many vaccine scientists. The move is the most far-reaching in a series of actions by Kennedy, a long-time vaccine skeptic, to reshape U.S. regulation of vaccines, food and medicine. Scientists and experts said the changes to the vaccine panel, which recommends how vaccines are used and by whom, would undermine public confidence in health agencies. Kennedy promised the move would raise public confidence. "Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," Kennedy said in a statement from the Department of Health and Human Services. Kennedy has for years sown doubt about the safety and efficacy of vaccines, but he pledged to maintain the country's existing vaccine standards to secure his appointment in President Donald Trump's administration. The Food and Drug Administration, which is overseen by Kennedy's department, has approved a number of vaccines during his tenure despite concerns over his stances. Even so, at least one senior Republican member of Congress expressed doubts about the changes in the panel. Kennedy said the Advisory Committee on Immunization Practices is rife with conflicts and has never turned down a vaccine, even though the decision to approve vaccines rests with the U.S. Food and Drug Administration. The CDC panel provides guidance to the CDC on which groups of people would most benefit from an already-approved vaccine. "That's a tragedy," said former FDA Chief Scientist Jesse Goodman. "This is a highly professional group of scientists and physicians and others... It's the kind of political meddling that will reduce confidence rather than increase confidence." The Pharmaceutical Research and Manufacturers of America called Kennedy's action concerning for public health. "Upending the ACIP membership increases uncertainty and vaccine skepticism, undermining the health gains achieved through vaccination," the industry body said in a statement late on Monday. Shares of vaccine makers Moderna and U.S.-listed shares of BioNTech fell more than 1%, while Pfizer was down marginally in extended trading on Monday. Kennedy said most panel members receive funding from drugmakers although members are required to declare any potential or perceived conflicts of interest that arise in the course of their tenure and any relevant business interests, positions of authority or other connections with organizations relevant to the committee's work. Kennedy and HHS provided no specific evidence of industry conflicts of interest among departing ACIP members. The CDC's web page for conflicts of interest, last updated in March, showed that one current member had recused herself from votes on a handful of vaccines because she had worked on clinical trials for their manufacturers. BIDEN APPOINTEES All 17 ACIP members were appointed under former President Joe Biden's administration, including 13 in 2024, HHS said. Without their removal, Trump's administration would not have been able to choose a majority of the committee until 2028. "This is not a political committee, it's never been partisan," said Dorit Reiss, a vaccine law expert at UC Law San Francisco. "It's an expert committee. Presidents have never been involved in ACIP membership." The decision drew criticism from Democrats in Congress, and one key Republican expressed concern. "Of course, now the fear is that the ACIP will be filled up with people who know nothing about vaccines except suspicion," said Republican U.S. Senator Bill Cassidy in a post on X. "I've just spoken with Secretary Kennedy, and I'll continue to talk with him to ensure this is not the case." Cassidy, a doctor from Louisiana who had expressed wariness about Kennedy's anti-vaccine views before clearing the path for him to become the nation's top health official, said at the time he had received assurances Kennedy would protect existing vaccination programs. The CDC panel will convene its next meeting June 25-27 at CDC headquarters in Atlanta, the department said. Vetting new panel members typically takes months, said one expert with close ties to the committee, who expressed doubts the newly appointed panel would be able to meet on time unless Kennedy and his team "have been working in the shadows" to onboard them months ahead of the announcement. Kennedy has drawn condemnation from health officials for his vaccine policies including what they say is a weak endorsement of the measles shots during an outbreak that has infected more than 1,000 mostly unvaccinated people and killed three. He announced last month the government was dropping its recommendation that healthy children and pregnant women should receive COVID shots, sidestepping the typical process. Traditionally, once the FDA approves vaccines for sale to the public, ACIP's role is to review data in a public meeting and vote on vaccine recommendations, which are then sent to the CDC director to sign off. The Affordable Care Act generally requires insurers to cover vaccines that are listed on the CDC vaccine schedules for adults and children. The recommendations also determine which vaccines the CDC's Vaccines for Children program will provide free of charge to those without insurance.
Yahoo
6 hours ago
- Yahoo
Lead concerns in Milwaukee Public Schools; new push for federal help
The Brief Wisconsin Sen. Tammy Baldwin is making a new push for federal help to address the lead concerns in Milwaukee Public Schools. Six MPS schools have been shut down in 2025 because of the lead concerns. Four remain closed. MILWAUKEE - Dangerous lead levels forced the closures of six Milwaukee Public Schools in 2025. Four of those six remain shut down. Now, there is a new push for federal help on the matter. What we know Westside Academy is one of six Milwaukee Public Schools shut down for dangerous lead levels. Koa Branch has two children who attend school there. Even before the lead problem at Westside, Branch regularly had her kids tested for lead. Moving schools was a test for her kindergartner, Jonas. What they're saying "We're getting them tested again, tonight. I'm just nervous about it, so I just test them whenever I feel I need to test them," Branch said. Other MPS parents shared similar problems during a roundtable with U.S. Senator Tammy Baldwin (D-Wisconsin) on Monday, June 9. FREE DOWNLOAD: Get breaking news alerts in the FOX LOCAL Mobile app for iOS or Android "I run a tight schedule. So, I'm used to my son getting off the bus at 2:36, so I can be at work by three, so now I'm getting late to work. I mean the communication with Brown Street is excellent, the transition, as far as getting them to school is excellent. But, it just took us out of our routine," said Santana Wells, a parent of a Brown Street School student. What we know Sen. Baldwin is now inviting U.S. Health and Human Services Secretary Robert Kennedy to visit Milwaukee and hear the stories from parents like Branch and Wells. "These children are people. It is not a blue or a red issue. This is everybody's issue," said Shyquetta McElroy, Coalition on Lead Emergency. SIGN UP TODAY: Get daily headlines, breaking news emails from FOX6 News The senator urges the Trump administration to reinstate laid off CDC lead experts. "They could make the situation better today, by rehiring these experts," Baldwin said. Dig deeper In April, the CDC told the Milwaukee Health Department it could not send a team of lead experts. The CDC blamed it on the complete loss of the lead program. Secretary Kennedy told reporters in April, he thought that the program was being reinstated. But Sen. Baldwin said she is still waiting. "He either was lying or he didn't know what was happening in his own department. And I don't know which is worse," Baldwin said. HHS said the CDC did help validate new lab equipment for Milwaukee's lead testing. A Milwaukee Health Department spokeswoman said that was a single lab tech who helped calibrate a new machine, not the team of experts once in discussions to come to Milwaukee. The Source The information in this post was produced by FOX6 News.
